Position in LLY
as of Jun 30, 2026
· filed Jul 24, 2026
Position Value
$3,206,076
+$732,815 QoQ
Shares Held
2,673
-0.6% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.37%
of 13F equity value
Holder Rank
#2,067
of 4,605 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 54%
Shared 0%
None 46%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026GREATMARK INVESTMENT PARTNERS, INC. holds $72,037,606 across 8 Drug Manufacturers - General names. LLY ranks #5 (4.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
114,692 | $29,128,327 | |
| 2 | AMGN |
Amgen Inc
|
71,294 | $25,816,983 | |
| 3 | ABBV |
AbbVie Inc.
|
36,732 | $9,243,240 | |
| 4 | GILD |
Gilead Sciences, Inc.
|
28,312 | $3,576,938 | |
| 5 | LLY |
ELI LILLY & Co
This page
|
2,673 | $3,206,076 | |
| 6 | MRK |
Merck & Co., Inc.
|
3,806 | $489,071 | |
| 7 | AZN |
Astrazeneca PLC
|
1,821 | $345,298 | |
| 8 | PFE |
Pfizer Inc
|
9,621 | $231,673 |
All Filings in LLY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,206,076 | 2,673 | Shares | Sole | 2026-07-24 | |
| 2026-03-31 | $2,473,261 | 2,689 | Shares | Sole | 2026-04-28 | |
| 2025-12-31 | $2,899,486 | 2,698 | Shares | Sole | 2026-01-27 | |
| 2025-09-30 | $1,905,974 | 2,498 | Shares | Sole | 2025-10-31 | |
| 2025-06-30 | $1,983,903 | 2,545 | Shares | Sole | 2025-07-30 | |
| 2025-03-31 | $2,101,940 | 2,545 | Shares | Sole | 2025-05-01 | |
| 2024-12-31 | $1,810,340 | 2,345 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $2,101,449 | 2,372 | Shares | Sole | 2024-10-31 | |
| 2024-06-30 | $2,147,561 | 2,372 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $1,856,990 | 2,387 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $1,354,123 | 2,323 | Shares | Sole | 2024-02-05 | |
| 2023-09-30 | $1,247,215 | 2,322 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $1,091,316 | 2,327 | Shares | Sole | 2023-08-02 | |
| 2023-03-31 | $860,953 | 2,507 | Shares | Sole | 2023-04-28 | |
| 2022-12-31 | $917,160 | 2,507 | Shares | Sole | 2023-01-30 | |
| 2022-09-30 | $810,638 | 2,507 | Shares | Sole | 2022-11-08 | |
| 2022-06-30 | $812,844 | 2,507 | Shares | Sole | 2022-07-28 | |
| 2022-03-31 | $717,929 | 2,507 | Shares | Sole | 2022-04-27 | |
| 2021-12-31 | $692,483 | 2,507 | Shares | Sole | 2022-02-03 | |
| 2021-09-30 | $579,242 | 2,507 | Shares | Sole | 2021-11-02 | |
| 2021-06-30 | $575,406 | 2,507 | Shares | Sole | 2021-08-23 | |
| 2021-03-31 | $468,357 | 2,507 | Shares | Sole | 2021-05-04 | |
| 2020-12-31 | $423,281 | 2,507 | Shares | Sole | 2021-02-08 | |
| 2020-09-30 | $374,786 | 2,532 | Shares | Sole | 2020-10-28 | |
| 2020-06-30 | $428,017 | 2,607 | Shares | Sole | 2020-08-04 | |
| 2020-03-31 | $389,387 | 2,807 | Shares | Sole | 2020-04-29 | |
| No filing history on record for this holder in this stock. | ||||||